The UK is finally getting back on its feet. Covid-19 was initially brushed aside by Prime Minister Boris Johnson before forcing the government to implement ever tighter restrictions. The pandemic triggered the worst recession in UK history (2020 GDP plummeted 9.8%) and caused 135,000 deaths, one of the heaviest tolls of the advanced economies. Now that more than 80% of the adult population has been vaccinated, the UK is finally exiting the crisis. Though still in the grips of the Delta variant, which is 40-60% more contagious than its predecessor, the “English” variant (renamed Alpha), the hospital system has reported only a mild upturn in severe cases (with at most 800 hospital admissions daily, down from nearly 4,000 at the height of the previous wave). With the reopening of business in phases since February, the economy has rebounded spectacularly, and has rapidly encountered supply-side constraints.
Supply and pricing pressures
Q2 2021 not only marked the end of a strict lockdown – it was even more severe than the one introduced during the first wave of the pandemic in spring 2020 – but was also a period of catharsis, during which British consumption surged at an annualised rate of more than 30%, and businesses bounced back, easily erasing the losses earlier in the year.
As in other countries where households benefited from massive support measures, curbs on spending led to the build-up of surplus savings, which are now flowing back into the economy. Indeed, demand is so strong that supply is struggling to keep up: in transportation, construction and throughout supply chains, delivery periods are getting longer and bottlenecks are forming. Companies are experiencing hiring troubles, even in recovering sectors like tourism and leisure, where job vacancies have reached record highs.
Of course, this is not a specifically British problem. It can be found just about anywhere due to a global shortage of components (Asia, the main supplier, is still struggling with the virus), congested maritime traffic, and commodity market pressures by China and the US. Yet in the UK, supply-side constraints have been exacerbated by Brexit, whose harmful effects are already palpable. With the return of immigration barriers to keep out European Union workers (visas, work permits, etc.), the obstacles to hiring and the recovery are not only cyclical. According to the Confederation of British Industry, the labour shortage could last two years.
These tensions are now carrying over to prices. At 3.2% in August, inflation has beaten the odds and soared to the highest level since 2012. Although base effects are to blame, the surge can also be attributed to the fact that coffee shops, hotels and restaurants were forced to operate at reduced capacity, leaving them no choice but to raise prices to meet the inflow of customers. The lifting of lockdown restrictions is also illustrated by strong pricing pressures on cars, notably used cars, much like the situation observed a few months ago in the United States.
With the upcoming VAT hikes (see below), the Bank of England (BoE) expects inflation to reach 4% by the end of the year, largely surpassing its 2% target. This inflationary surge is nonetheless expected to be short lived, and the central bank does not intend to raise its base rate, currently set at 0.10%, until the economy has fully recovered. That condition has not been met yet. Although midway through 2021 economic activity is nearing pre-pandemic levels, there is still a shortfall of a little over 4 points of GDP. Yet closing the remaining gap is likely to be much harder, since the Johnson government plans to begin removing fiscal support measures this fall and to raise social welfare contributions in April 2022.
The end of “whatever the cost”
In the UK, like in most of the “liberal” advanced economies (such as the US, Canada and Australia), public support measures deployed during the health crisis have helped offset the relative weakness of social welfare shock absorbers. They have proved to play a vital role. According to estimates by the International Monetary Fund (IMF), the UK injected no less than GBP 340 billion (16 points of GDP) into the economy in 2020-21, a record for Europe. Although “whatever the cost” is no longer fully justified, its removal will nonetheless serve as a test case.
Fiscal support measures have already begun to be withdrawn. At the end of September, the government ended its main job retention schemes, namely the Coronavirus Job Retention Scheme (CJRS) and the Self-Employed Income Support Scheme (SEISS). Introduced in March and April 2020 these two programmes benefited roughly 14.5 million workers (payroll employees and the self-employed) and largely helped reduce the rise in unemployment, which barely rose above 5% at the height of the crisis. As the economy has recovered, these schemes have been allowed to expire. But for the 1.6 million employees still furloughed in their companies, this could prove to be a difficult awakening.
If the current labour shortage can facilitate the transition, things did not stop there. In addition to the job subsidies, the GBP20-a-week boost to universal credit was also eliminated for some 6 million British citizens. Moreover, all households will be hit by the increase in the reduced VAT rate for hotel and restaurant services (to rise from 5% to 12.5% in October 2021, then to 20% in April 2022). And the stamp duty holiday was reduced from GBP 500,000 to GBP 250,000 in July, and will be slashed to GBP 125,000 in October.
No “singapore-on-thames”
Last March, Rishi Sunak, the Chancellor of the Exchequer, announced that the corporate tax rate would be raised from 19% to 25% as of 1 April 2023, raising some grumbles from Brexit supporters who had been dreaming of a “Singapore-on-Thames”. The government’s plans, which aim to raise roughly GBP 12 billion in additional revenues annually, is not anecdotal. Granted, it only applies to a minority of companies (the 30% that report earnings of more than GBP 50,000 a year) and will be offset during the previous two fiscal years (2021- 22 and 2022-23) by a “super tax deduction” equivalent to 130% of fixed capital investment. Even so, it is the first corporate tax hike since 1974, when the Labour government of Harold Wilson raised to corporate tax rate from 40% to 52%, and an earth-shaking move within the Conservative party, which has always made corporate tax cuts the hallmark of its policies.
Lastly, to support the National Health System (NHS), whose spending soared by roughly GBP 100 billion (2.5 points of GDP) during the pandemic, Prime Minister Boris Johnson intends to raise the social welfare contribution by 1.25 points for employers (from 13.8% to 15.05%), employees (from 12% to 13.25%), and on dividends (from 7.5% to 8.75%). Effective as of April 2022, the permanent measure should generate additional revenues estimated at GBP 12 billion a year. It would also halt the erosion of NHS revenues, which as a share of GDP have declined constantly since 2010.
Already perceptible through the drop-off in real estate transactions and the downturn in purchasing manager indices (PMI), the slowdown in the economy is keeping pace with the shift in government policy. As it translates into growth figures, the economic slowdown could be especially visible by the end of the year, as the upturn in inflation erodes household purchasing power.
BNP Paribas is regulated by the FSA for the conduct of its designated investment business in the UK and is a member of the London Stock Exchange. The information and opinions contained in this report have been obtained from public sources believed to be reliable, but no representation or warranty, express or implied, is made that such information is accurate or complete and it should not be relied upon as such. This report does not constitute a prospectus or other offering document or an offer or solicitation to buy any securities or other investment. Information and opinions contained in the report are published for the assistance of recipients, but are not to be relied upon as authoritative or taken in substitution for the exercise of judgement by any recipient, they are subject to change without notice and not intended to provide the sole basis of any evaluation of the instruments discussed herein. Any reference to past performance should not be taken as an indication of future performance. No BNP Paribas Group Company accepts any liability whatsoever for any direct or consequential loss arising from any use of material contained in this report. All estimates and opinions included in this report constitute our judgements as of the date of this report. BNP Paribas and their affiliates ("collectively "BNP Paribas") may make a market in, or may, as principal or agent, buy or sell securities of the issuers mentioned in this report or derivatives thereon. BNP Paribas may have a financial interest in the issuers mentioned in this report, including a long or short position in their securities, and or options, futures or other derivative instruments based thereon. BNP Paribas, including its officers and employees may serve or have served as an officer, director or in an advisory capacity for any issuer mentioned in this report. BNP Paribas may, from time to time, solicit, perform or have performed investment banking, underwriting or other services (including acting as adviser, manager, underwriter or lender) within the last 12 months for any issuer referred to in this report. BNP Paribas, may to the extent permitted by law, have acted upon or used the information contained herein, or the research or analysis on which it was based, before its publication. BNP Paribas may receive or intend to seek compensation for investment banking services in the next three months from an issuer mentioned in this report. Any issuer mentioned in this report may have been provided with sections of this report prior to its publication in order to verify its factual accuracy. This report was produced by a BNP Paribas Group Company. This report is for the use of intended recipients and may not be reproduced (in whole or in part) or delivered or transmitted to any other person without the prior written consent of BNP Paribas. By accepting this document you agree to be bound by the foregoing limitations. Analyst Certification Each analyst responsible for the preparation of this report certifies that (i) all views expressed in this report accurately reflect the analyst's personal views about any and all of the issuers and securities named in this report, and (ii) no part of the analyst's compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed herein. United States: This report is being distributed to US persons by BNP Paribas Securities Corp., or by a subsidiary or affiliate of BNP Paribas that is not registered as a US broker-dealer, to US major institutional investors only. BNP Paribas Securities Corp., a subsidiary of BNP Paribas, is a broker-dealer registered with the Securities and Exchange Commission and is a member of the National Association of Securities Dealers, Inc. BNP Paribas Securities Corp. accepts responsibility for the content of a report prepared by another non-US affiliate only when distributed to US persons by BNP Paribas Securities Corp. United Kingdom: This report has been approved for publication in the United Kingdom by BNP Paribas London Branch, a branch of BNP Paribas whose head office is in Paris, France. BNP Paribas London Branch is regulated by the Financial Services Authority ("FSA") for the conduct of its designated investment business in the United Kingdom and is a member of the London Stock Exchange. This report is prepared for professional investors and is not intended for Private Customers in the United Kingdom as defined in FSA rules and should not be passed on to any such persons. Japan: This report is being distributed to Japanese based firms by BNP Paribas Securities (Japan) Limited, Tokyo Branch, or by a subsidiary or affiliate of BNP Paribas not registered as a financial instruments firm in Japan, to certain financial institutions permitted by regulation. BNP Paribas Securities (Japan) Limited, Tokyo Branch, a subsidiary of BNP Paribas, is a financial instruments firm registered according to the Financial Instruments and Exchange Law of Japan and a member of the Japan Securities Dealers Association. BNP Paribas Securities (Japan) Limited, Tokyo Branch accepts responsibility for the content of a report prepared by another non-Japan affiliate only when distributed to Japanese based firms by BNP Paribas Securities (Japan) Limited, Tokyo Branch. Hong Kong: This report is being distributed in Hong Kong by BNP Paribas Hong Kong Branch, a branch of BNP Paribas whose head office is in Paris, France. BNP Paribas Hong Kong Branch is regulated as a Licensed Bank by the Hong Kong Monetary Authority and is deemed as a Registered Institution by the Securities and Futures Commission for the conduct of Advising on Securities [Regulated Activity Type 4] under the Securities and Futures Ordinance Transitional Arrangements. Singapore: This report is being distributed in Singapore by BNP Paribas Singapore Branch, a branch of BNP Paribas whose head office is in Paris, France. BNP Paribas Singapore is a licensed bank regulated by the Monetary Authority of Singapore is exempted from holding the required licenses to conduct regulated activities and provide financial advisory services under the Securities and Futures Act and the Financial Advisors Act. © BNP Paribas (2011). All rights reserved.
Recommended Content
Editors’ Picks
EUR/USD trades weak below 1.0800 amid Good Friday lull, ahead of US PCE
EUR/USD remains depressed below 1.0800 after soft French inflation data, amid minimal volatility and thin liquidity on Good Friday. The pair keenly awaits the US PCE inflation data and Fed Chair Powell's speech for fresh hints on next week's price action.
GBP/USD holds steady above 1.2600 as markets stay calm on Good Friday
GBP/USD trades sideways above 1.2600 amid a typical Good Friday trading lull. A broadly firmer US Dollar could keep any upside attempts limited in the pair ahead of the US PCE inflation data and Fed Chair Powell's appearance.
Gold price sits at all-time highs above $2,230, US PCE eyed
Gold price hit all-time highs at $2,236 on Thursday to finish Q1 2024 with a bang. Most major world markets, including the US are closed due to Holy Friday, leaving volatility around Gold price highly subdued. US PCE inflation and Powell are awaited.
Jito price could hit $6 as JTO coils up inside this bullish pattern
Jito (JTO) price has been on an uptrend since forming a local bottom in early January. Since then, JTO has revisited the key swing point formed in early December, suggesting the bulls’ intention to move higher.
Key events in developed markets next week
Next week, the main focus will be inflation and the labour market in the Eurozone. We expect services inflation to be impacted by the easter effect, while the unemployment rate to be unchanged.